EUVIMEDEUVIMED entdecken
Crossref

Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors

Miguel Antonio Lasheras-Pérez iD, María Concepción Garrido-Ruiz, Alejandro Lobato-Berezo, Rodolfo David Palacios-Diaz iD, Irene Albert-Cobo, Giuseppe Gallo iD, Virginia Velasco-Tamariz, Ricardo Ruiz-Villaverde, Rocío Gil-Redondo iD, Conrad Pujol-Marco, Rosa María García-Martín, María Del Mar Blanes-Martínez und 13 weitere

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.70084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Miguel Antonio Lasheras-Pérez und 24 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, La Fe University and Polytechnic Hospital, Valencia, Spain. Hauptthemen laut MEDLINE: Lichen Planus, Folliculitis, Janus Kinase Inhibitors, Alopecia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lichen planopilaris (LPP) and folliculitis decalvans (FD) are two of the most common types of primary scarring alopecia. Several Janus kinase inhibitors (JAKis) have been used effectively in their treatment. We conducted an immunohistochemical (IHC) study to evaluate whether any member of the JAK family was overexpressed in the primary inflammatory infiltrate of FD and LPP. Additionally, we performed an exploratory retrospective study on the efficacy and safety of oral JAKis in LPP.

Methods

Pathology scalp samples from seven healthy controls and 28 patients with LPP or FD were selected for staining with anti‐JAK1, anti‐JAK2, anti‐JAK3, and anti‐TYK2 antibodies. Cases and controls were compared using the H‐score of the inflammatory cells. On the other hand, an exploratory retrospective clinical study was conducted in which patients with LPP who were treated with JAKis for at least three months were included. Clinical characteristics, severity scores, and the presence of adverse events were collected.

Results

The IHC study determined that JAK1 and JAK2 exhibited similar expression patterns in cases and controls. However, JAK3 and TYK2 were expressed solely in cases of primary scarring alopecia and were negative in the controls. In the exploratory clinical study, 19 patients with LPP were treated with JAKis. Severity scores improved in follow‐up visits, with adverse events generally being mild.

Conclusions

JAK3 and TYK2 were overexpressed in LPP and FD samples compared to healthy controls, supporting JAKs as potential pharmacological targets of interest. JAKis could be an effective and safe treatment for LPP patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lichen PlanusFolliculitisJanus Kinase InhibitorsAlopeciaScalp DermatosesHumansMaleFemaleRetrospective StudiesMiddle AgedAdultImmunohistochemistryJanus Kinase 1Janus Kinase 2Janus Kinase 3Administration, OralAgedCase-Control StudiesScalpYoung AdultSeverity of Illness IndexAbnormalities, MultipleEyebrowsDarier Disease

Stichwörter der Autor:innen

Janus kinase inhibitorsfolliculitis decalvanslichen planopilarispersonalized medicinescarring alopecia

Substanzen

Janus Kinase InhibitorsJanus Kinase 1Janus Kinase 2JAK1 protein, humanJanus Kinase 3JAK2 protein, humanJAK3 protein, human

Autor:innen und Institutionen

  • Dermatology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Health Research Institute Hospital La Fe, Valencia, Spain.
  • Pathology Department, 12 de Octubre University Hospital, Madrid, Spain.
  • Institute I+12, Madrid, Spain.
  • Pathology Department, Complutense University of Madrid, Madrid, Spain.
  • Department of Dermatology, Hospital del Mar, Barcelona, Spain.

ORCID-Profile: Miguel Antonio Lasheras-Pérez, Rodolfo David Palacios-Diaz, Giuseppe Gallo, Rocío Gil-Redondo, Jorge Magdaleno-Tapial, Simone Ribero

Zitieren

APA

Lasheras-Pérez, M. A., Garrido-Ruiz, M. C., Lobato-Berezo, A., Palacios-Diaz, R. D., Albert-Cobo, I., Gallo, G., Velasco-Tamariz, V., Ruiz-Villaverde, R., Gil-Redondo, R., Pujol-Marco, C., García-Martín, R. M., Blanes-Martínez, M. D. M., Escutia-Muñoz, B., Magdaleno-Tapial, J., Rodríguez-Serna, M., Sahuquillo-Torralba, A., Ribero, S., Gelato, F., Llavador-Ros, M., …, & Botella-Estrada, R. (2025). Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors. International Journal of Dermatology. https://doi.org/10.1111/ijd.70084

Vancouver

Lasheras-Pérez MA, Garrido-Ruiz MC, Lobato-Berezo A, Palacios-Diaz RD, Albert-Cobo I, Gallo G, et al. Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors. International Journal of Dermatology. 2025. doi:10.1111/ijd.70084

BibTeX
@article{LasherasPrez2025,
  author = {Lasheras-Pérez, Miguel Antonio and Garrido-Ruiz, María Concepción and Lobato-Berezo, Alejandro and Palacios-Diaz, Rodolfo David and Albert-Cobo, Irene and Gallo, Giuseppe and Velasco-Tamariz, Virginia and Ruiz-Villaverde, Ricardo and Gil-Redondo, Rocío and Pujol-Marco, Conrad and García-Martín, Rosa María and Blanes-Martínez, María Del Mar and Escutia-Muñoz, Begoña and Magdaleno-Tapial, Jorge and Rodríguez-Serna, Mercedes and Sahuquillo-Torralba, Antonio and Ribero, Simone and Gelato, Federica and Llavador-Ros, Margarita and Martínez-Cózar, Vicent and Pantoja Borja, Nicolay S and Lo Sicco, Kristen I and Shapiro, Jerry and Rodríguez-Peralto, José Luis and Botella-Estrada, Rafael},
  title = {Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.70084}
}
Kostenlos starten →